NCT06344728

A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants

A Phase 1, Open-Label, Randomized, Two-Period Crossover Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets Following Single Oral Doses in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Insmed Incorporated · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The primary purpose of this study is to determine the relative bioavailability of brensocatib between the pediatric oral solution and oral tablets in healthy participants.

Conditions

• Healthy Participants

Interventions

Type	Name	Description
DRUG	Brensocatib Oral Solution	Brensocatib solution
DRUG	Brensocatib Oral Tablet	Brensocatib tablet

Timeline

• Start date: 2024-04-30
• Primary completion: 2024-05-24
• Completion: 2024-05-24
• First posted: 2024-04-03
• Last updated: 2024-06-13

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study